|
⚲
|
| Ancora Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001401177 |
| Sale | 2009-11-09 ($0.8 M Sold) |
| Fund | |
| Phone | 7813957700 |
| Address | 200 Boston Ave Medford, 02155 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Peter Seeberger | |
| Doug Jamison | |
| Barry Buckland | |
| Karl White | |
| Mitsi Ushio | |
| John Pena | |
| Carmichael Roberts |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
PC RECAP Ivan Woods, LLC
✚
|
0.0 | |
|
PCRP Leapfrog, LP
✚
|
0.0 | |
|
PDC Rittiman LP, LTD
✚
|
0.0 | |
|
PDL Biopharma Inc
✚
|
0.0 | |
|
PDP E. Deer Valley Drive Partners, LLC
✚
|
0.0 | |
|
Peach State Bancshares, Inc.
✚
|
0.0 | |
|
Peachtree Hotel Opportunity Zone Tax Advantage Fund II, LP
✚
|
0.0 | |
|
Peacock Capital MF Fund I LLC
✚
|
0.0 | |
|
Peak Housing REIT, Inc.
✚
|
0.0 | |
|
Pcpre Group 15 LLC
✚
|
0.0 |